Management of CVD in Patients with Diabetes

How would the recent 2022 ADA consensus and 2023 ESC recommendations help physicians mitigate CVD risk in T2DM patients? It is widely recognised that individuals with type 2 diabetes are at increased risk of developing cardiovascular diseases such as coronary...

Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients

Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers 

Uncovering the Cardio-renal Risks of Chinese T2DM patients: Back to the Future with CUHK!

Management of Diabetes in Japan – Can Patients Play a More Significant Role?

T2DM Patient Support Program in Hong Kong and the Value of NT-proBNP

Role of Diagnostics: NT-proBNP in management of Heart Failure

Taking Diabetes to Heart: Value of Cardiovascular Biomarkers for your Diabetic Patients

NT-proBNP: Increasing Clinical Confidence in Heart Failure Management

Heart Failure Prevention in T2DM – Essence of JCS/JDS joint consensus

CVD Management in T2DM – JCS and JDS Joint Consensus

APSC hs-TnT Consensus & Future Use of Biomarker in T2DM & COVID-19

2800+ Healthcare Professionals have cardiac insights delivered to their inbox
Sign up to receive the latest updates via your email
Keep me informed